US has reclosed its southern border after a flesh-eating parasite is seen further north in Mexico
Mexico's president was critical Thursday, suggesting that the U.S. is exaggerating the threat to its beef industry from the parasite, the New World screwworm fly. The female flies lay eggs in wounds on warm-blooded animals, hatching larvae that are unusual among flies for feeding on live flesh and fluids instead of dead material.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNET
3 minutes ago
- CNET
This Free Heat Warning System Could Help You Prepare for Dangerous Summer Conditions
A massive heat dome is gripping much of the US again this week, with the Midwest facing a brutal combination of scorching temperatures and stifling humidity due in part to so-called "corn sweat," or the extra moisture crops release into the air. This added humidity is pushing heat indexes well above 100 degrees across parts of the Corn Belt and beyond, compounding the risks for millions under excessive heat warnings and advisories. The extreme heat bearing down across the US this summer can have a serious impact on public health. Excess heat can exacerbate common health conditions, but it can also mess with your air conditioning, overheat phones and cause meltdowns for other tech. If you live in an area at risk for extreme heat, or know someone who does, you can sign up for a free alert system to help you prepare. The HeatRisk tool from the National Weather Service can send personalized warnings straight to your inbox, giving you advance notice when dangerously high temperatures are headed your way. HeatRisk is free to use and you'll want to keep tabs on it to avoid heat safety issues, such as heatstroke, dehydration or fatigue. Here's how to use it and why you should. Read more: This CDC Tool Can Help You Track Heat Risks on Trips and in Your Area What is NWS HeatRisk? Heat across the US in summer 2025. Screenshot by Macy Meyer/CNET NWS HeatRisk is a clickable map of the US, which is used to forecast extreme heat and assess the impact of that weather on public health. You can click anywhere on the interactive map and pull up a seven-day forecast of risk assessments for any city, town or area. The threat assessment is built on a five-level system that's color-coded for severity, with green representing little to no risk and magenta representing the highest risk. The map will display a seven-day forecast for anywhere in the country, along with the color of the health threat level. The system also considers how unusual the heat is for your area, how long the heat is expected to last and how it could affect people who are more vulnerable, such as older adults, kids or outdoor workers. Read more: Super Common Health Conditions Can Make a Heat Wave More Dangerous: Here's How to Prepare Threat colors NWS HeatRisk has five levels, each with a different color that corresponds to the size of the health risk: 0: Green According to the NWS tool, there's little to no risk involved with the forecasted heat at the green level. 1: Yellow At the yellow level, there's a minor risk for people who are extremely sensitive to heat. 2: Orange The orange level represents a moderate risk to the general public, with potential danger to health systems and heat-sensitive industries. 3: Red Red means there's a major risk to anyone without access to immediate cooling and hydration, with likely impacts to health systems and heat-sensitive industries. 4: Magenta The most extreme level is magenta. It's both a rare occurrence and one that's of long duration, with no overnight relief and is likely to affect health systems, heat-sensitive industries and infrastructure. How to sign up for heat risk alerts To get free heat warnings, go to enter your ZIP code and sign up for email or text alerts. You'll get daily updates when your area faces extreme heat levels that could pose a health risk. Signing up for alerts is a quick step that could help you plan ahead, from adjusting outdoor activities to checking on family or neighbors, or just opting to stay hydrated and inside. Other ways to track heat risks Similar to NWS HeatRisk, a tool from the US Centers for Disease Control and Prevention called the HeatRisk Dashboard gives you a seven-day forecast to assess the potential health impact from extreme heat. Data Explorer is another tool from the CDC's Environmental Public Health Tracking Program, which offers further HeatRisk information and assessment resources for COVID-19 and other illnesses. Read more: Here's How to Keep Your Kitchen Cool (and Lower Your Energy Bill) During a Heat Wave Why extreme heat warnings matter Summer 2025 has already been a scorcher in many parts of the country. It's important to stay diligent since extreme heat is the deadliest weather hazard in the US, causing more deaths each year than hurricanes, floods or tornadoes. The risks of heat are only growing. Heat waves are lasting longer, nighttime temperatures are staying high and unusual humidity -- like the current "corn sweat" in the Midwest -- can make it even harder for your body to cool down. Staying informed is one of the easiest ways to protect yourself and your loved ones. Along with signing up for alerts, the CDC recommends learning the signs of heat-related illnesses, drinking plenty of water and never leaving children or pets in cars. For more ways to stay safe this summer, check out CNET's guide to the best portable AC units, tips for cooling down this summer and how to make your home more heat-resilient.
Associated Press
3 minutes ago
- Associated Press
Scientist.com Expands Tumor Model Finder with XenoSTART's Highly Relevant, Patient-Derived Tumor Models
SAN DIEGO--(BUSINESS WIRE)--Jul 23, 2025-- the leading R&D procurement orchestration platform for the life sciences, today announced a major expansion of its Tumor Model Finder (TMF) following a strategic partnership with XenoSTART, a global leader in patient-derived xenograft (PDX) model development and testing. The addition of hundreds of unique and high-demand XenoSTART models pushes the TMF past a milestone of 10,000 searchable oncology models, giving cancer researchers unprecedented access to diverse and clinically relevant tools. 'Pharma discovery teams often face critical delays accessing translational research partners with deeply characterized PDX models that accurately reflect real-world patient disease complexity,' said Michael J. Wick, PhD, Chief Scientific Officer at XenoSTART. 'By joining the marketplace, XenoSTART eliminates this significant barrier, providing immediate access to our highly relevant, patient-derived tumor models that are directly linked to our global clinical network. This integration empowers drug developers to confidently accelerate therapeutic decision-making and precisely guide their translational strategies—ultimately speeding effective cancer treatments to patients.' Tumor Model Finder is a centralized, AI-powered platform that aggregates and standardizes tumor model data from 20+ leading CROs. It allows researchers to search, compare, and source PDX, CDX, organoid, and cell line models—spanning 17 cancer types—through a single workflow. The platform also includes drug response profiles, genomic alterations (e.g., KRAS, BRAF mutations), and RNA seq-based gene expression data to support informed model selection and study design. 'XenoSTART's contribution significantly boosts the depth and quality of our TMF offerings,' said Javier Pineda, PhD, Director of Preclinical AI at 'Researchers can now find models with richer data and greater relevance to their specific cancer studies.' This collaboration also highlights the translational impact of START's global research ecosystem. With patient-derived tissue samples sourced from START's expansive oncology trial network, XenoSTART's models provide critical continuity between preclinical evaluation and clinical trial execution—helping pharmaceutical companies make faster, more confident decisions in oncology drug development. To learn more or schedule a demo of the Tumor Model Finder, email [email protected]. About is the life-science industry's premier AI-powered marketplace and procurement-orchestration platform. Founded in 2007 and headquartered in Solana Beach, California, the company simplifies every stage of drug discovery and development by unifying supplier search, competitive bidding, contracting, compliance and analytics in a single, secure workspace. More than 20 of the world's top 30 pharma companies, 100+ biotech organizations and the US National Institutes of Health rely on to access a vetted network of 6,000+ specialized providers, shorten cycle times and reduce costs while meeting the highest ethical and regulatory standards. Visit to discover how we accelerate science. About XenoSTART Founded in 2007, XenoSTART is a translational research organization dedicated to advancing oncology drug development through clinically relevant preclinical cancer models. The XenoSTART Patient-Derived Xenograft (XPDX) platform features more than 2,800 models across a broad range of tumor types and disease stages sourced from patients treated at START's domestic and international cancer centers. Models are deeply characterized using histologic analysis, DNA/RNA sequencing, and in vivo drug sensitivity testing, and are clinically annotated with the donor patient's treatment history and clinical outcome. By bridging real-world tumor biology with rigorous preclinical science, XenoSTART enables pharmaceutical partners to make smarter, faster decisions from bench to bedside. Learn more about XenoSTART at View source version on CONTACT: Sean Preci +1 877-644-3044 [email protected] XenoSTART Lauren Panco 609-216-4920 KEYWORD: EUROPE UNITED STATES NORTH AMERICA CALIFORNIA INDUSTRY KEYWORD: OTHER HEALTH RESEARCH PHARMACEUTICAL ONCOLOGY TECHNOLOGY ARTIFICIAL INTELLIGENCE GENETICS HEALTH TECHNOLOGY SCIENCE BIOTECHNOLOGY OTHER SCIENCE HEALTH SOURCE: Copyright Business Wire 2025. PUB: 07/23/2025 07:55 AM/DISC: 07/23/2025 07:55 AM
Forbes
12 minutes ago
- Forbes
Europe's Quiet Digital Health Revolution: 6 Experts' Views
As Europe's healthcare systems grapple with aging populations, rising chronic disease, and overburdened clinicians, digital health is no longer a niche—it's a necessity. But how is Europe's approach distinct from the U.S. and Asia? And what will it take to translate promise into scalable impact? I asked six leading voices across venture, policy, and clinical innovation for their take on what's exciting, what's holding us back, and what success could really look like. The digital health market in Europe is expected to exceed US$ 260 billion by 2030. A compound annual ... More growth rate of 22.7% is expected of Europe digital health market from 2025 to 2030. Digital health is evolving rapidly across Europe. What's exciting you most right now? Tobias Silberzahn, Senior Fellow for BSt Gesundheit: 'Digitally-enabled chronic disease management (especially for diabetes, obesity, mental health, and cardiovascular disease). These diseases cause 90% of deaths and 80% of healthcare costs in Europe. The WHO just published a European digital health action plan with strong language on chronic care and promising case studies. The momentum is finally building.' Aditi U. Joshi, CEO; Author, Telehealth Success: 'What excites me most about digital health in Europe is the drive to build in collaboration with multiple stakeholders. The funding for large digital initiatives is in place and helps provide infrastructure to start the journey. At the same time, newer companies are also able to address these same problems in a more agile and iterative manner. The combination of both approaches is rare and may produce long-term success.' Dr. Patrick Pfeffer, Managing Partner at Aescuvest: 'What excites me most is how AI is transforming diagnosis, clinical workflows, and decision support—and how the investment landscape is increasingly supporting these innovations.' Fredrik Debong, Founder & Partner, 'The biggest near-term impact will come from applying AI where data density and clinical relevance already intersect. Diabetes is the clearest example: continuous glucose, insulin, and behavioral data make it a live testbed for algorithmic breakthroughs, and costs to build have dropped by an order of magnitude in just a few years. Execution speed now decides winners. Founders can increasingly pick their investors—choose those who live and breathe these complex systems. In chronic care, deep domain focus isn't optional; it's the difference between building another app and reshaping how millions manage their health.' Gabrielle Powell, Digital Health Advisor & Entrepreneur: 'Europe's established primary care infrastructure, combined with its commitment to data privacy and patient rights, is laying the groundwork for truly patient-centered digital solutions.' Matteo Berlucci, CEO & CoFounder, Healthily: 'There is growing recognition that new digitally-enabled operating models for care delivery, especially for primary and chronic care, will be the way forward for health systems in Europe. This is creating space for new ecosystem collaborations across providers, pharma, tech, and public and private payors.'The recent HLTH Europe and HIMSS conferences generated buzz especially around digital health. What stood out? Aditi U. Joshi: 'The two conferences had very different focuses—HLTH was more industry- and investor-facing, while HIMSS dove deep into provider systems. Together, they painted a fuller picture of where Europe is heading. The excitement around value-based care and population health is present at both, and it's interesting to see the maturity of organizations and health systems ready to take on new delivery models.' Dr. Patrick Pfeffer: 'What stood out most was how AI and health data governance dominated discussions. It's clear these aren't just tech trends—they're becoming core to health system reform.' Fredrik Debong: 'I finally see the pieces we've been speaking about for years come together. It's becoming real.' Gabrielle Powell: 'The focus on an ecosystem view of healthcare stood out. There's increasing recognition that collaboration across sectors and geographies is essential for meaningful innovation.' Matteo Berlucci: 'Europe is not 'behind'—it is just on a different trajectory, shaped by the unique mix of public systems and local contexts. The conferences demonstrated how important it is for European stakeholders to chart their own path, even while learning from others. And there's a fresh sense of urgency to address clinician burnout, patient access, and population health—especially as chronic disease rises.'Where do you see the biggest opportunities for impact in digital health in Europe in the next 12–18 months? Tobias Silberzahn: 'Digitally-enabled chronic disease management (especially for diabetes, obesity, mental health, and cardiovascular disease). This is where the highest costs and worst outcomes are—and where digital has most potential to help.' Aditi U. Joshi: 'I have seen that there is an opportunity to scale virtual care programs across regions, in areas that may not have had traditional services. Virtual programs that are proactive, inclusive, and designed with usability in mind have the best chance for success.' Dr. Patrick Pfeffer: 'Over the next 12–18 months, I see the greatest impact in digital therapeutics and AI-enabled mental health tools. These can deliver measurable outcomes at scale, especially in underserved populations.' Fredrik Debong: 'A swiftly dawning realisation of need among policymakers and payors—that if we do not act now, we will fall behind. This opens the door for accelerated action and adoption.' Gabrielle Powell: 'The scaling of AI scribes from pilot programmes to real-world implementation will free up clinicians and improve documentation quality—arguably the biggest bottleneck today.' Matteo Berlucci: 'The most immediate opportunity is to integrate virtual and hybrid care models into mainstream health systems, especially to manage chronic conditions and mental health. We are seeing interest from both governments and private insurers—but execution is everything.'What barriers still hold the digital health sector back—and how can they be overcome? Tobias Silberzahn: 'Reimbursement codes are often lacking (e.g., for digital therapeutics), which prevents scaling. We need systemic changes to make innovation financially viable for providers.' Aditi U. Joshi: 'Digital health faces barriers from fragmented systems and regulatory hurdles. But aligning incentives for all players—providers, payors, and patients—can accelerate adoption.' Dr. Patrick Pfeffer: 'Two key barriers remain: societal acceptance and reimbursement. Overcoming these will require sustained education and clearer outcome-based payment models.' Fredrik Debong: 'Still disparate regulations between countries, still lack of harmonisation. Also, not enough focus on the how of adoption—not just what tech should be used, but how it fits into existing care and economic systems.' Gabrielle Powell: 'The primary barrier to the scaling of digital health solutions in Europe is the challenge of implementation. Even with great tools and willing users, systems are not designed for agile experimentation or rapid scaling. That needs to change.' Matteo Berlucci: 'Too many pilots, not enough procurement. Innovation often stalls because health systems struggle to fund or operationalize new models beyond the pilot stage. Stronger public-private partnerships and more flexible reimbursement pathways could help.'How is Europe approaching responsible AI in healthcare compared to other regions? Aditi U. Joshi: 'Europe leads with a strong focus on ethics and transparency. This helps build trust, which is critical to widespread AI adoption in healthcare.' Dr. Patrick Pfeffer: 'Europe may not be the fastest adopter of AI in healthcare, but it is arguably the most principled. The EU AI Act is an important step in ensuring responsible deployment of these technologies.' Fredrik Debong: 'High level and ethically, far better than elsewhere. But practically, we still lag in implementation. There's a gap between principle and practice.' Gabrielle Powell: 'From a regulatory perspective, Europe leads globally. The EU AI Act sets a precedent for ensuring transparency, accountability, and fairness in health applications.' Matteo Berlucci: 'Europe's approach emphasizes trust, equity, and long-term societal impact—which is commendable. The challenge now is to balance this with speed and scalability.'Final thoughts: What will success look like for European digital health in the near future? Tobias Silberzahn: '- Establishing reimbursement categories for patient-centered, tech-enabled chronic disease management – Embedding new digital workflows for primary and chronic care into care teams – Expanding new roles (e.g., digital care navigators) to support both patients and clinicians – Training and upskilling 100,000s of clinicians and nurses in digital tools – Keeping patients at the center' Aditi U. Joshi: 'The dream is efficient, quality care powered by tech—but without losing the human connection. That balance will define success.' Dr. Patrick Pfeffer: 'Success will mean nothing less than a redefinition of care delivery—more predictive, more participatory, and more personalized.' Fredrik Debong: 'I assume that this is about local deployment, sustainability, and measurable change—not hype, not the 'next cool thing.'' Gabrielle Powell: 'Success in digital health will come as much from governance, education, and implementation science as from the technologies themselves.' Matteo Berlucci: 'Success will mean that digital tools are no longer seen as 'add-ons' but as core to how we deliver care—equitably, efficiently, and compassionately.'Europe's digital health future won't be defined by any single technology or country—it will be shaped by systems that prioritize equity, usability, and impact. The experts in this roundtable are aligned on one thing: while Europe's approach may be slower and more fragmented, it also has the potential to build something more enduring, ethical, and human-centered. Now is the moment to move from pilots to platforms—and from promise to practice.
